<DOC>
	<DOCNO>NCT01470053</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety mometasone furoate plus azelastine HCl patient perennial allergic rhinitis .</brief_summary>
	<brief_title>Efficacy Safety Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone Azelastine Alone Patients With Perennial Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Azelastine</mesh_term>
	<criteria>Patients 12 year age Medical history perennial allergic rhinitis least two year Moderate ro severe nasal symptom ( placebo runin period AM rTNSS PM rTNSS≥8 ) Positive skin prick test result within previous 12 month patient active asthma require therapy inhaled oral corticosteroid longterm βagonist patient severe rhinostenosis , severely deviate nasal septum local infection nasal mucous membrane patient herpes zoster , glaucoma cataract patient history operation damage nasal cavity ocular region patient druginduced rhinitis patient history respiratory infection require antibiotic therapy within previous 14 day Patients lung disease include COPD Patients history immunotherapy ongoing immunotherapy patient administer super potent potent corticosteroid patient administer intramuscular intraarticular steroid within previous 3 month patient administer subcutaneous omalizumab within previous 5 month</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>mometasone furoate</keyword>
	<keyword>azelastine HCl</keyword>
	<keyword>perennial allergic rhinitis</keyword>
</DOC>